|
2018
|
Invention
|
Biaryloxy derivatives as ttx-s blockers. The present invention relates to biaryloxy derivatives w... |
|
|
Invention
|
Fxr receptor agonist. The present invention relates to the technical field of pharmacy, and speci... |
|
2017
|
Invention
|
Salt of a quinazoline derivative-like tyrosine kinase inhibitor and crystal form thereof. Provide... |
|
|
Invention
|
Salt of quinazoline derivative-like tyrosine kinase inhibitor and crystal form thereof. Provided ... |
|
|
Invention
|
Quinazoline derivatives substituted by aniline, preparation method and use thereof. 6, L and n ha... |
|
|
Invention
|
Quinazoline derivatives substituted by aniline, preparation method and use thereof.
The inventio... |
|
|
Invention
|
Crystalline form of succinate used as dipeptidyl peptidase-4 inhibitor. The present invention rel... |
|
|
Invention
|
Antibacterial composition and use thereof. The present invention relates to the technical field o... |
|
|
Invention
|
Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application ... |
|
|
Invention
|
Fxr receptor agonist. Provided in the present invention is a compound represented by the followin... |
|
2016
|
Invention
|
Crystals of quinazoline derivative and preparation method therefor. The invention relates to Crys... |
|
|
Invention
|
Crystals of quinazoline derivative and preparation method therefor. The present invention relates... |
|
|
Invention
|
Crystalline form of benzoate of dipeptidyl peptidase-iv inhibitor. The present invention relates ... |
|
|
Invention
|
Preparation method for 1,4-dihydropyridine-3,5-dicarboxylate derivative, and intermediate. Provid... |
|
|
Invention
|
Β-lactamase inhibitors and uses thereof. 2, M and ring A have definitions as those in the specifi... |
|
|
Invention
|
.beta.-lactamase inhibitors and uses thereof. Provided are compounds shown in general formulae (I... |
|
|
Invention
|
Β-lactamase inhibitor and application thereof. Provided are compounds shown in general formulae (... |
|
|
Invention
|
Benzimidazole derivatives and their pharmaceutical compositions and uses.
The present invention ... |
|
2015
|
Invention
|
High selectivity substituted pyrimidine pi3k inhibitor. The present invention relates to a substi... |
|
|
Invention
|
Polycyclic anaplastic lymphoma kinase inhibitor. As represented by formula (I), a polycyclic anap... |
|
|
Invention
|
Tyrosine kinase inhibitor and uses thereof. Disclosed is a compound of Formula (I) or a pharmaceu... |
|
|
Invention
|
Tyrosine kinase inhibitor and uses thereof. The present invention relates to compounds, as repres... |
|
2014
|
Invention
|
Kinase inhibitor and use thereof. The invention relates to a CDK4/6 kinase inhibitor, or a pharma... |
|
|
Invention
|
Kinase inhibitor and use thereof. The present invention relates to a CDK4/6 kinase inhibitor, and... |
|
|
Invention
|
Substituted pyrido[2,3-c]pyridazin-4(1h)-ones as tumor necrosis factor alpha and phosphodiesteras... |
|
|
Invention
|
Quadri-fused cyclic anaplastic lymphoma kinase inhibitor. Provided are the compounds as shown by ... |
|
|
Invention
|
Pi3k and/or mtor inhibitor prodrug. Provided are a compound as represented by general formula (I)... |
|
|
Invention
|
Bicyclic substituted pyrimidine pde-5 inhibitor prodrug. Provided are a bicyclic substituted pyri... |
|
|
Invention
|
Tetrazocyclokinase inhibitor. The present invention relates to the field of medical technologies,... |
|
2013
|
Invention
|
Pi3k and/or mtor inhibitor. 4, X, Y, A and B are as defined in the specification. The present inv... |
|
|
Invention
|
Pi3k and/or mtor inhibitor. Provided are a class of compounds of general formula (I), pharmaceuti... |
|
|
Invention
|
Bicyclic substituted pyrimidine compounds. The present invention relates to the technical field o... |
|
2012
|
Invention
|
Three-ring pi3k and/or mtor inhibitor. The present application relates to a compound as represent... |
|
|
Invention
|
Fused ring-containing oxazolidinones antibiotics. 6, A, B and C are as defined in the description... |
|
|
Invention
|
Oxazolidinone antibiotics containing fused ring. The present invention relates to an oxazolidinon... |
|
|
Invention
|
Biaryl heterocycle substituted oxazolidinone antibacterial agents. 5, A and B are as defined in t... |
|
|
Invention
|
Biaryl heterocycle substituted oxazolidinon antibacterial drug. The present invention relates to ... |
|
|
Invention
|
Heterocyclic substituted pyrimidine compound. The present invention belongs to the field of medic... |
|
|
Invention
|
Crystal form i of salt of dipeptidyl peptidase-iv inhibitor and preparation method and use thereo... |
|
|
Invention
|
C-glycoside derivatives. Disclosed are compounds as shown as general formula (I), derivatives and... |
|
|
Invention
|
Pyridonaphthyridine type dual pi3k and mtor inhibitor and its preparation and use. 7 and X are as... |
|
|
Invention
|
Pyridonaphthyridine pi3k/mtor dual inhibitors and preparation and use thereof. The present invent... |
|
|
Invention
|
1,4-dihydropyridine -3,5-dicarboxylate derivatives, preparation methods and uses thereof. Disclos... |
|
2011
|
Invention
|
Benzimidazole derivatives and their pharmaceutical compositions and uses. 5 and n have the defini... |
